Patents by Inventor Richard Schulick

Richard Schulick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATING A DISEASE OR DISORDER
    Publication number: 20220235136
    Abstract: The present application provides agents that specifically inhibits the IGFBP7/CD93 signaling pathway, such as agents that specifically block the interaction between CD93 and IGFBF7, methods of using said agents and methods of identifying said agents.
    Type: Application
    Filed: March 25, 2022
    Publication date: July 28, 2022
    Applicants: YALE UNIVERSITY, The Regents of the University of Colorado, a body corporate
    Inventors: Yuwen ZHU, Lieping CHEN, Richard SCHULICK, Yi SUN
  • Listeria-induced immunorecruitment and activation, and methods of use thereof
    Publication number: 20070190029
    Abstract: Provided are reagents and methods for administering an attenuated bacterium for use in treating a cancerous or infectious condition. Reagents and methods for administering an attenuated bacterium for use in inducing an immune response against a tumor, cancer cell, or infective agent are further provided. Also provided are methods of diagnosis and kits.
    Type: Application
    Filed: August 21, 2006
    Publication date: August 16, 2007
    Applicants: Cerus Corporation, The Johns Hopkins University
    Inventors: Drew Pardoll, Richard Schulick, Keith Bahjat, Dirk Brockstedt, Thomas Dubensky, Martin Giedlin, Kiyoshi Yoshimura, Ajay Jain
  • Methods and compositions for the targeting of a systemic immune response to specific organs or tissues
    Publication number: 20060051380
    Abstract: The invention provides methods and compositions for targeting a separately generated immune response to a specific organ or tissue, e.g. one affected by cancer, using one or more agents with a tropism for the organ or tissue or that can be specifically localized to the desired organ or tissue. For example, the invention provides methods ands compositions for treating liver metastases from colorectal cancer using a combination of a granulocyte/macrophage colony stimulating factor (GM-CSF) augmented tumor cell vaccination and Listeria monocytogenes (LM) infection.
    Type: Application
    Filed: February 6, 2003
    Publication date: March 9, 2006
    Applicant: The Johns Hopkins University
    Inventors: Richard Schulick, Drew Pardoll, Ajay Jain